Serina Therapeutics SER
NYSE SER
$1.78 +0.01 (+0.56%)
As of: Oct 22, 2026 · 2:35 PM EDT

Serina Therapeutics (SER) Interest Paid (2023 - 2024)

Updated

Analysis

Serina Therapeutics (SER) Interest Paid (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.07 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.25 Bn
10 Serina Therapeutics 29.17 Mn -11.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -2,000.00
Jun 30, 2024 1,000.00
Mar 31, 2024 1,000.00
Dec 31, 2023 23,000.00
API Access

Serina Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=SER&period=max&api_key=YOUR_API_KEY